BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1820 related articles for article (PubMed ID: 32588191)

  • 1. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophagocytic syndrome and COVID-19.
    Retamozo S; Brito-Zerón P; Sisó-Almirall A; Flores-Chávez A; Soto-Cárdenas MJ; Ramos-Casals M
    Clin Rheumatol; 2021 Apr; 40(4):1233-1244. PubMed ID: 33389315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
    Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
    BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
    Opoka-Winiarska V; Grywalska E; Roliński J
    BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Liu JM; Chi J
    Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine Storm Syndrome.
    Cron RQ; Goyal G; Chatham WW
    Annu Rev Med; 2023 Jan; 74():321-337. PubMed ID: 36228171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
    Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
    Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
    Hakim NN; Chi J; Olazagasti C; Liu JM
    Exp Biol Med (Maywood); 2021 Jan; 246(1):5-9. PubMed ID: 32972235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.
    Griffin G; Shenoi S; Hughes GC
    Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101515. PubMed ID: 32387063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.
    Chu R; van Eeden C; Suresh S; Sligl WI; Osman M; Cohen Tervaert JW
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.
    Nakanuma S; Gabata R; Okazaki M; Seki A; Hosokawa K; Yokoyama T; Katano K; Sugita H; Tokoro T; Takada S; Makino I; Taniguchi T; Harada K; Yagi S
    Transplant Proc; 2023 Oct; 55(8):1946-1950. PubMed ID: 37537076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome.
    Valade S; Mariotte E; Azoulay E
    Crit Care Clin; 2020 Apr; 36(2):415-426. PubMed ID: 32172822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
    Alfaro-Murillo A; Lazo-Paéz G
    Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS; Nigrovic PA; Platt CD; Priebe GP; Rowe J; Sundel RP; Surana NK; Weinacht KG; Mann A; Yuen JC; Meleedy-Rey P; Starmer A; Banerjee T; Dedeoglu F; Degar BA; Hazen MM; Henderson LA
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):7. PubMed ID: 30764840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
    Soy M; Keser G; Atagündüz P; Tabak F; Atagündüz I; Kayhan S
    Clin Rheumatol; 2020 Jul; 39(7):2085-2094. PubMed ID: 32474885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.